Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
161
NMPA:161
Drug Approvals
Alendronate Sodium Tablets
- Product Name
- 阿仑膦酸钠片
- Approval Number
- 国药准字H20093921
- Approval Date
- Mar 4, 2024
NMPA
Cefteram Pivoxil Tablets
- Product Name
- 头孢特仑新戊酯片
- Approval Number
- 国药准字H20133323
- Approval Date
- May 23, 2023
NMPA
Thiamphenicol Enteric-coated Tablets
- Product Name
- 甲砜霉素肠溶片
- Approval Number
- 国药准字H20073858
- Approval Date
- Mar 9, 2022
NMPA
Citicoline Sodium and Sodium Chloride Injection
- Product Name
- 彼迪明
- Approval Number
- 国药准字H20020319
- Approval Date
- Mar 9, 2022
NMPA
Ofloxacin and Sodium Chloride Injection
- Product Name
- 氧氟沙星氯化钠注射液
- Approval Number
- 国药准字H10940239
- Approval Date
- Jan 25, 2022
NMPA
Compound Amino Acid Injection(17AA)
- Product Name
- 复方氨基酸注射液(17AA)
- Approval Number
- 国药准字H19993672
- Approval Date
- Oct 28, 2021
NMPA
Compound Amino Acid Injection(15AA)
- Product Name
- 复方氨基酸注射液(15AA)
- Approval Number
- 国药准字H19999252
- Approval Date
- Oct 28, 2021
NMPA
Compound Amino Acid Injection(17AA-I)
- Product Name
- 复方氨基酸注射液(17AA-Ⅰ)
- Approval Number
- 国药准字H44024831
- Approval Date
- Oct 28, 2021
NMPA
Compound Amino Acid Injection(17AA-I)
- Product Name
- 复方氨基酸注射液(17AA-Ⅰ)
- Approval Number
- 国药准字H44025415
- Approval Date
- Oct 28, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
Clinical Trials
No trials found
News
No news found